검색어: 6 guidance on performing stress tests (핀란드어 - 덴마크어)

note for guidance on evaluation of
points to consider on clinical investigation of medicinal products for the management of crohn’ s disease

note for guidance on carcinogenic potential
note for guidance on carcinogenic potential

nimi note for guidance on development pharmaceutics
titel note for guidance on development pharmaceutics

revised note for guidance on repeated dose toxicity
revised note for guidance on repeated dose toxicity

medicinal products note for guidance on specifications: test
note for guidance on specifications: test procedures and acceptance criteria for

asiakirjan nimi note for guidance on postmenopausal osteoporosis in women
titel på dokumentet note for guidance on postmenopausal osteoporosis in women

note for guidance on development pharmaceutics for veterinary medicinal products
note for guidance on development pharmaceutics for veterinary medicinal products.

recombinant coagulation factor ix products note for guidance on the clinical
core spc for human plasma derived and recombinant coagulation factor ix products

addendum to note for guidance on plasma- derived medicinal products
addendum to note for guidance on plasma- derived medicinal products

note for guidance on pharmaceutical aspects of the product literature for human vaccines
note for guidance on pharmaceutical aspects of the product literature for human vaccines

asiakirjan nimi note for guidance on the clinical investigation of plasma derived antithrombin products
titel på dokumentet note for guidance on the clinical investigation of plasma derived antithrombin products

concept paper on the development of a cpmp note for guidance on the clinical pharmacokinetic investigation of
concept paper on the development of a cpmp note for guidance on the clinical pharmacokinetic investigation of the pharmacokinetics of peptides and proteins.

annex to note for guidance on stability testing of new active substances and medicinal products.
annex to note for guidance on stability testing of new active substances and medicinal products.

annex to note for guidance on stability testing of existing active substances and related finished products.
annex to note for guidance on stability testing of existing active substances and related finished products.

asiakirjan nimi update of note for guidance on non- clinical local tolerance testing of medicinal products
titel på dokumentet update of note for guidance on non- clinical local tolerance testing of medicinal products

concept paper on the development of a cpmp note for guidance on the use of medicinal products during pregnancy:
concept paper on the development of a cpmp note for guidance on the use of medicinal products during pregnancy:

asiakirjan nimi revision of note for guidance on carcinogenic potential (3bs7a, volume 3b, 1998, p.
titel på dokumentet revision of note for guidance on carcinogenic potential (3bs7a, volume 3b, 1998, p.

guidance on pre- approval information for registration of new veterinary medicinal products for food producing animals with respect to antimicrobial resistance
guidance on pre- approval information for registration of new veterinary medicinal products for food producing animals with respect to antimicrobial resistance

asiakirjan nimi annex to note for guidance on development pharmaceutics (cpmp/ qwp/ 155/ 96):
titel på dokumentet annex to note for guidance on development pharmaceutics (cpmp/ qwp/ 155/ 96):

note for guidance on evaluation of anticancer medicinal products in man (cpmp/ ewp/ 205/ 95 rev.
note for guidance on evaluation of anticancer medicinal products in man (cpmp/ ewp/ 205/ 95 rev.